Report of the 15th European Stroke Conference, Brussels, May 16-19, 2006.
Mohr
J P
JP
Neurological Institute, Columbia University College of Physicians and Surgeons, New York, NY 10029, USA. jpm10@columbia.edu
D000925:Anticoagulants / Q000627:therapeutic use; D001530:Belgium; D002986:Clinical Trials as Topic; D003029:Coagulants / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D020521:Stroke / Q000188:drug therapy* / Q000517:prevention & control*
D000925:Anticoagulants; D003029:Coagulants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors